ALLMedicine™ Keratoconjunctivitis Sicca Center
Research & Reviews 195 results
https://clinicaltrials.gov/ct2/show/NCT04440280
Jan 26th, 2023 - Fuchs Endothelial Corneal Dystrophy (FECD) is the most common corneal endothelial disorder and has been estimated to affect approximately 4% of the US population over the age of 40. Corneal transplantation is currently the primary treatment modali...
https://emedicine.medscape.com/article/1191641-print
Jan 24th, 2023 - Practice Essentials Giant papillary conjunctivitis (GPC), also called contact lens–induced papillary conjunctivitis (CLPC), is a common complication of contact lens wear.[1] First described by Spring,[2, 3, 4, 5] GPC is characterized by hypersensi...
http://emedicine.medscape.com/article/1191641-overview
Jan 24th, 2023 - Practice Essentials Giant papillary conjunctivitis (GPC), also called contact lens–induced papillary conjunctivitis (CLPC), is a common complication of contact lens wear. [1] First described by Spring, [2, 3, 4, 5] GPC is characterized by hypersen...
https://emedicine.medscape.com/article/1191641-overview
Jan 24th, 2023 - Practice Essentials Giant papillary conjunctivitis (GPC), also called contact lens–induced papillary conjunctivitis (CLPC), is a common complication of contact lens wear. [1] First described by Spring, [2, 3, 4, 5] GPC is characterized by hypersen...
https://doi.org/10.1016/j.amjms.2022.12.005
The American Journal of the Medical Sciences; Collins B, Dillon D et. al.
Dec 20th, 2022 - A rare overlap syndrome between CREST (calcinosis, Raynaud phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia) syndrome and primary biliary cholangitis (PBC) is described as PACK syndrome, an acronym for primary biliary cholangi...
Drugs 15 results see all →
Clinicaltrials.gov 34 results
https://clinicaltrials.gov/ct2/show/NCT04440280
Jan 26th, 2023 - Fuchs Endothelial Corneal Dystrophy (FECD) is the most common corneal endothelial disorder and has been estimated to affect approximately 4% of the US population over the age of 40. Corneal transplantation is currently the primary treatment modali...
https://clinicaltrials.gov/ct2/show/NCT03418259
Dec 13th, 2022 - The purpose of the study is to evaluate how treatment with Intra-Nasal Mechanical Stimulation (INMEST) in the nasal cavity in patients with Keratoconjunctivitis sicca can relieve these symtoms.
https://clinicaltrials.gov/ct2/show/NCT05633524
Dec 2nd, 2022 - Sjögren's syndrome (SS) is an autoimmune disorder characterized by chronic salivary and lacrimal gland dysfunction leading to dry mouth (xerostomia) and dry eye (xerophthalmia) sensation (1). Although dry mouth and dry eye are the main symptoms, t...
https://clinicaltrials.gov/ct2/show/NCT05320172
Sep 19th, 2022 - There are many conditions in which the ocular surface is severely affected as keratoconjunctivitis sicca, persistent epithelial corneal defect, recurrent corneal erosion, neurotrophic keratopathy, post laser in-situ keratomileusis (LASIK) ocular s...
https://clinicaltrials.gov/ct2/show/NCT02688556
Aug 29th, 2022 - This is a randomized, double-masked, vehicle-controlled study of the safety and efficacy of OTX-101 (0.09% cyclosporine nanomicellar solution) in the treatment of keratoconjunctivitis sicca to be conducted at approximately 50 sites.
News 16 results
https://www.medscape.com/viewarticle/982258
Nov 10th, 2022 - Dry eye disease (DED), also known as dry eye syndrome, keratoconjunctivitis sicca (KCS), and keratitis sicca, is a multifactorial disease of the ocular surface due to a loss of homeostasis of the tear film. It often results in ocular symptoms and ...
https://www.medscape.com/viewarticle/967849
Feb 3rd, 2022 - The US Food and Drug Administration (FDA) has approved the first generic of cyclosporine ophthalmic emulsion (Restasis) to treat keratoconjunctivitis sicca (dry eye). Restasis has been approved by the FDA since 2003 and works to help increase tear...
https://www.medpagetoday.com/ophthalmology/generalophthalmology/96989
Feb 2nd, 2022 - The FDA approved the first generic of cyclosporine ophthalmic emulsion (Restasis) for dry eye, a condition that affects millions of Americans each year. Cyclosporine ophthalmic emulsion is a commonly prescribed immunomodulator with anti-inflammato...
https://reference.medscape.com/viewarticle/922805_4
Jan 29th, 2020 - Recognizing the patterns of joint involvement seen in psoriatic arthritis is essential to its diagnosis. Five patterns have been identified. They are: Asymmetrical oligoarticular arthritis Symmetrical polyarthritis Arthritis mutilans Distal interp...
https://www.medscape.com/viewarticle/900888
Aug 17th, 2018 - The US Food and Drug Administration (FDA) has approved cyclosporine A ophthalmic solution 0.09% (Cequa, Sun Pharmaceuticals) to increase tear production in patients with keratoconjunctivitis sicca (dry eye), the company has announced. Cequa is a p...